The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  He, Yuqi ^a   Gong, Lei ^b   Fang, Yaping ^c   Zhan, Qi ^d   Liu, Hui Xin ^a   Lu, Yanliu ^a   Guo, Grace L ^e   Lehman McKeeman, Lois ^b   Fang, Jianwen ^f   Wan, Yu Jui Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^e RUTGERS UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chromatin immunoprecipitation; Farnesnoid x receptor; Liver x receptor; Microarray; Nuclear receptor; Peroxisomal proliferator activated receptor ; Pregnane x receptor; Retinoic acid receptor; Retinoids x receptor; Sequencing

Indexed keywords

BILE ACID; CHOLESTEROL; FARNESOID X RECEPTOR; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREGNANE X RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RETINOID X RECEPTOR ALPHA; SATURATED FATTY ACID; TRANSCRIPTOME; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; CELL RECEPTOR; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE SEQUENCE; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPOLYSIS; LIVER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BINDING SITE; BLOOD; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GENOME; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; BILE ACIDS AND SALTS; BINDING SITES; CHOLESTEROL; GENE EXPRESSION REGULATION; GENOME; HOMEOSTASIS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTOME; TRETINOIN; TRIGLYCERIDES;

EID: 84883128543     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-575     Document Type: Article

References (35)

1. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol 2006, 66:606-630. 10.1002/neu.20242, 16688755.
2. Bushue N, Wan YJ. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 2010, 62:1285-1298. 10.1016/j.addr.2010.07.003, 2991380, 20654663.
3. Mukherjee R, Strasser J, Jow L, Hoener P, Paterniti JR, Heyman RA. RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol 1998, 18:272-276. 10.1161/01.ATV.18.2.272, 9484993.
4. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995, 9:1033-1045. 10.1101/gad.9.9.1033, 7744246.
5. Urizar NL, Dowhan DH, Moore DD. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem 2000, 275:39313-39317. 10.1074/jbc.M007998200, 10998425.
6. Lemay DG, Hwang DH. Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J Lipid Res 2006, 47:1583-1587. 10.1194/jlr.M500504-JLR200, 16585784.
7. Wang K, Chen S, Xie W, Wan YJ. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem Pharmacol 2008, 75:2204-2213. 10.1016/j.bcp.2008.02.030, 2742682, 18400206.
8. Chen S, Wang K, Wan YJ. Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. Biochem Pharmacol 2010, 79:270-276. 10.1016/j.bcp.2009.08.012, 2784018, 19686701.
9. Wan YJ. Retinoic acid and its receptors. Am J Surg 1993, 166:50-53. 10.1016/S0002-9610(05)80581-1, 8392301.
10. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000, 20:4436-4444. 10.1128/MCB.20.12.4436-4444.2000, 85811, 10825207.
11. Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Sucov HM. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J Biol Chem 2000, 275:28285-28290.
12. Gyamfi MA, He L, French SW, Damjanov I, Wan YJ. Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury. J Pharmacol Exp Ther 2008, 324:443-453.
13. Gyamfi MA, Tanaka Y, He L, Klaassen CD, Wan YJ. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. Toxicol Appl Pharmacol 2009, 234:166-178. 10.1016/j.taap.2008.09.022, 2656443, 18952117.
14. Cai Y, Konishi T, Han G, Campwala KH, French SW, Wan YJ. The role of hepatocyte RXR alpha in xenobiotic-sensing nuclear receptor-mediated pathways. Eur J Pharm Sci 2002, 15:89-96. 10.1016/S0928-0987(01)00211-1, 11803135.
15. Dai G, Chou N, He L, Gyamfi MA, Mendy AJ, Slitt AL, Klaassen CD, Wan YJ. Retinoid X receptor alpha Regulates the expression of glutathione s-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver. Mol Pharmacol 2005, 68:1590-1596.
16. Gyamfi MA, Kocsis MG, He L, Dai G, Mendy AJ, Wan YJ. The role of retinoid X receptor alpha in regulating alcohol metabolism. J Pharmacol Exp Ther 2006, 319:360-368. 10.1124/jpet.106.108175, 16829625.
17. Wan YJ, Han G, Cai Y, Dai T, Konishi T, Leng AS. Hepatocyte retinoid X receptor-alpha-deficient mice have reduced food intake, increased body weight, and improved glucose tolerance. Endocrinology 2003, 144:605-611. 10.1210/en.2002-221003, 12538623.
18. Cui JY, Gunewardena SS, Rockwell CE, Klaassen CD. ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res 2010, 38:7943-7963. 10.1093/nar/gkq654, 3001051, 20693526.
19. Boergesen M, Pedersen TA, Gross B, Van Heeringen SJ, Hagenbeek D, Bindesboll C, Caron S, Lalloyer F, Steffensen KR, Nebb HI, et al. Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor alpha in Mouse Liver Reveals Extensive Sharing of Binding Sites. Mol Cell Biol 2012, 32:852-867. 10.1128/MCB.06175-11, 3272984, 22158963.
20. Thomas AM, Hart SN, Kong B, Fang J, Zhong XB, Guo GL. Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology 2010, 51:1410-1419. 10.1002/hep.23450, 20091679.
21. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000, 20:4436-4444. 10.1128/MCB.20.12.4436-4444.2000, 85811, 10825207.
22. Mader S, Chen JY, Chen Z, White J, Chambon P, Gronemeyer H. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. EMBO J 1993, 12:5029-5041. 413763, 8262045.
23. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000, 14:2819-2830. 10.1101/gad.844900, 317055, 11090130.
24. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, Staels B. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 2004, 53:890-898. 10.2337/diabetes.53.4.890, 15047603.
25. Theken KN, Deng Y, Kannon MA, Miller TM, Poloyac SM, Lee CR. Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism. Drug Metab Dispos 2011, 39:22-29. 10.1124/dmd.110.035287, 3014271, 20947618.
26. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999, 285:1276-1279. 10.1126/science.285.5431.1276, 2720027, 10455056.
27. Henkel J, Frede K, Schanze N, Vogel H, Schurmann A, Spruss A, Bergheim I, Puschel GP. Stimulation of fat accumulation in hepatocytes by PGE(2)-dependent repression of hepatic lipolysis, beta-oxidation and VLDL-synthesis. Lab Invest 2012,
28. Zeisel SH. Choline: needed for normal development of memory. J Am Coll Nutr 2000, 19:528S-531S. 10.1080/07315724.2000.10718976, 11023003.
29. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, Vance DE. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab 2006, 3:321-331. 10.1016/j.cmet.2006.03.007, 16679290.
30. Imaizumi K, Mawatari K, Murata M, Ikeda I, Sugano M. The contrasting effect of dietary phosphatidylethanolamine and phosphatidylcholine on serum lipoproteins and liver lipids in rats. J Nutr 1983, 113:2403-2411.
31. Zhan Q, Fang Y, He Y, Liu H-X, Fang J, Wan Y-JY. Function annotation of hepatic retinoid x receptor a based on genome-wide DNA binding and transcriptome profiling. PLOS one 2012, 7:e50013. 10.1371/journal.pone.0050013, 3499475, 23166811.
32. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25. 10.1186/gb-2009-10-3-r25, 2690996, 19261174.
33. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008, 9:R137. 10.1186/gb-2008-9-9-r137, 2592715, 18798982.
34. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P. PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinforma 2010, 11:415.
35. Da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.